SCHEMBL4529374

SCHEMBL4529374

N[C@@H](Cc1cnc2ccccc2n1)C(=O)ON1C(=O)c2ccccc2C1=O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.50
CYP2C9 P11712 2/20 0.50
HIF1A Q16665 1/20 0.50
PDE10A Q9Y233 6/20 0.43
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
MAPT P10636 2/20 0.39
HSP90AA1 P07900 1/20 0.37
HSP90AB1 P08238 1/20 0.37
KDM4E B2RXH2 3/20 0.36
ALDH1A1 P00352 3/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
ALOX15 P16050 2/20 0.36
GAA P10253 2/20 0.36
NPC1 O15118 1/20 0.36
NFKB1 P19838 1/20 0.36
RAB9A P51151 1/20 0.36
NFKB2 Q00653 1/20 0.36
RELA Q04206 1/20 0.36
FAAH O00519 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27268932 0.77 PKM (0.51) CYP1A2CYP2C9KMT2AALDH1A1SMN1; SMN2
SCHEMBL23782003 0.76 CYP1A2 (0.55) CYP1A2CYP2C9HIF1APDE10AMEN1
SCHEMBL4523017 0.76 CYP1A2 (0.55) CYP1A2CYP2C9HIF1APDE10AMEN1
Hydrochloric Acid SCHEMBL6408746 0.75 CYP1A2 (0.53) CYP1A2CYP2C9HIF1APDE10AMEN1
SCHEMBL7307307 0.72 GLA (0.45) ALDH1A1SMN1; SMN2GAANPC1RAB9A
SCHEMBL7301262 0.71 DPP4 (0.40) CYP1A2CYP2C9MAPTALDH1A1SMN1; SMN2
SCHEMBL4521715 0.69 CYP1A2 (0.53) CYP1A2CYP2C9HIF1APDE10AMEN1
SCHEMBL15599302 0.67 CYP1A2 (1.00) CYP1A2CYP2C9HIF1APDE10AMEN1
SCHEMBL27695116 0.67 ALDH1A1 (0.45) CYP1A2CYP2C9KMT2AMAPTKDM4E
SCHEMBL3676819 0.65 LMNA (0.45) CYP1A2CYP2C9KMT2AMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050080263-A1 Method for producing ss-heteroaryl-alpha-alanine compounds using 2-amino-2-(heteroarylmethyl) carboxylic acid compounds CHIRACON GMBH (DE) 2005-04-14 US claimed
US-7626022-B2 Racemic mixtures; oxidation; cyclization; crystallization CHIRACON GMBH (DE) 2009-12-01 US disclosed
US-20050080263-A1 Method for producing ss-heteroaryl-alpha-alanine compounds using 2-amino-2-(heteroarylmethyl) carboxylic acid compounds CHIRACON GMBH (DE) 2005-04-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050080263-A1 Method for producing ss-heteroaryl-alpha-alanine compounds using 2-amino-2-(heteroarylmethyl) carboxylic acid compounds AAAS, ASNS, AADAT CYP1A2 95/4885CYP2C9 120/4885HIF1A 3789/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.